The University of Chicago Header Logo

Connection

Mark Kozloff to Receptors, TNF-Related Apoptosis-Inducing Ligand

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Receptors, TNF-Related Apoptosis-Inducing Ligand.
Mark Kozloff
Connection Strength
0.116
Receptors, TNF-Related Apoptosis-Inducing Ligand
  1. TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial. Cancer. 2013 Dec 15; 119(24):4290-8.
    View in: PubMed
    Score: 0.116
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.